How to buy Adherium (ADR) shares
Learn how to easily invest in Adherium shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Adherium Limited is a medical devices business based in Australia. Adherium shares (ADR) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Adherium has a trailing 12-month revenue of around $401,000. If you're looking to buy shares, check out the steps below.
How to buy shares in Adherium
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Adherium. Find the share by name or ticker symbol: ADR. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Adherium reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Adherium. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Adherium stock price (ASX:ADR)Use our graph to track the performance of ADR stocks over time.
Adherium shares at a glance
|52-week range||$0.015 - $0.034|
|50-day moving average||$0.0161|
|200-day moving average||$0.0167|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.017|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Adherium stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Adherium price performance over time
|1 week (2021-10-12)||-6.67%|
|1 month (2021-09-17)||-17.65%|
|3 months (2021-07-19)||-22.22%|
|6 months (2021-04-19)||-12.50%|
|1 year (2020-10-19)||-48.15%|
|2 years (2019-10-18)||-72.00%|
|3 years (2018-10-16)||-82.50%|
|5 years (2016-10-19)||-96.11%|
|Gross profit TTM||$-25,000|
|Return on assets TTM||-67.79%|
|Return on equity TTM||-172.64%|
|Market capitalisation||$31.9 million|
TTM: trailing 12 months
Adherium share dividends
We're not expecting Adherium to pay a dividend over the next 12 months.
Adherium share price volatility
Over the last 12 months, Adherium's shares have ranged in value from as little as $0.015 up to $0.034. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Adherium's is 2.2262. This would suggest that Adherium's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. The company offers Hailie, an asthma and COPD medication adherence solution for patients with chronic respiratory diseases. It also provides smart device sensors for respiratory medications, such as Bluetooth enabled Hailie sensors wrap around a patient's existing inhalers and automatically send usage data to their smartphone; and Hailie app that enables patients, caregivers, and healthcare professionals to track medication adherence, set daily reminders, into their medication usage. In addition, the company offers digital health solutions to patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company was incorporated in 2001 and is headquartered in Auckland, New Zealand.
Stocks similar to Adherium
Adherium in the news
Frequently asked questions
More guides on Finder
Why is the RIO share price lagging other miners today?
Shares in mining giant Rio Tinto are up just 7% in the last 12 months.
How to invest in the Rocketboots IPO
Everything we know about the Rocketboots IPO, plus information on how to buy in.
Top Bitcoin exchanges
With 30+ platforms available to buy Bitcoin from in Australia, it can be overwhelming to choose. Our experts have compared exchanges so you don’t have to.
How to invest in the Winsome Resources IPO
Everything we know about the Winsome Resources IPO, plus information on how to buy in.
Adore Beauty discount codes October 2021 | Up to 35% off: Clearance Sale
Get up to 35% off from these Adore Beauty discount codes, Australia’s leading online-only beauty and cosmetics store offering great products for men and women.
THE ICONIC discount codes October 2021 | Up to 60% off: Mid-Season Sale
All deals are checked and updated daily. Get the latest discount codes from THE ICONIC to save 60% instantly.
Why is the a2 Milk (A2M) share price on a high?
Shares in the trans-Tasman dairy company are down 55% over the last 12 months.
Why has the Bank of Queensland (BOQ) share price stumbled?
Shares in the Brisbane-based lender have risen nearly 60% in the last 12 months.
Today’s ASX top stocks: Deep Yellow (DYL ↑23.1%), Paladin Energy (PDN ↑23.0%)
The 10 biggest movers on the ASX for Wednesday 13 October 2021.
Ask an Expert